Top 10 Books about Stock Investing to read in 2018. Read more.

ARNA - Arena Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

ARNA - Arena Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Thu 15'th Feb 2018

PERIOD 2017-11-16 - 2018-02-15
CHANGE -0.51%
PRICE $40.77






Arena Pharmaceuticals Stock Analysis

Technical stock analysis for Thu 15'th Feb 2018

Shorts 2.62% ( 2018-01-31 )
Cash 579.7 mill
Loans 256.0 mill
Beta 1.49
ROA -13.80
Buy candidate since 2018-02-09 Gain 2.75%

Arena Pharmaceuticals fell by -0.51% in the last day from $40.98 to $40.77 The price has risen in 6 of the last 10 days and is up by 5.1% over the past 2 weeks. Volume has increased in the last day by 54 924 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 419 386 shares bought and sold for approximately $17.10 million.

Access today's Top 5 Buy Candidates


Arena Pharmaceuticals lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 39.85% during the next 3 months and, with 90% probability hold a price between $52.99 and $66.48 at the end of this period.

Click here for today's Top 5 Trending Companies


Arena Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $40.02 and $37.81. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday February 14, 2018, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 64 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Arena Pharmaceuticals finds support from accumulated volume at $40.17. On the upside the stock meets some resistance just above today's level from accumulated volume at $40.84, $40.98 and $41.10.

The stock is about to test the resistance from accumulated volume at $40.84 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $40.17 Price: $40.77 Resistance: $40.84


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.53 between high and low, or 6.45%. For the last week, the stock has had a daily average volatility of 6.35%.

Our recommended stoploss: $38.95 (-4.45%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Strong Buy Candidate to a Buy Candidate.

Trade ARNA CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).